This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Should Value Investors Pick Universal Health (UHS) Stock?
by Zacks Equity Research
Let's see if Universal Health (UHS) stock is a good choice for value-oriented investors right now from multiple angles.
Acadia Healthcare (ACHC) Q4 Earnings Miss, Revenues Meet
by Zacks Equity Research
Acadia Healthcare (ACHC) Q4 earnings miss, down year over year on increase in expenses.
Universal Health's (UHS) Q4 Earnings Beat Estimates, Up Y/Y
by Zacks Equity Research
Universal Health's (UHS) fourth-quarter results gain from its healthy top-line growth.
What's in Store for Universal Health (UHS) Q4 Earnings?
by Zacks Equity Research
Universal Health's (UHS) earnings in the fourth quarter are likely to gain from higher admissions and patient days.
Universal Health Services (UHS) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Universal Health Services (UHS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Anthem's (ANTM) Q4 Earnings Beat Estimates, Improve Y/Y
by Zacks Equity Research
Anthem's (ANTM) Q4 earnings surge on the back of operating performance and strong growth across all core businesses.
HCA Healthcare's (HCA) Q4 Earnings Top Estimates, Surge Y/Y
by Zacks Equity Research
HCA Healthcare's (HCA) fourth-quarter earnings rise on the back of robust same facility admissions.
What's in the Cards for Anthem (ANTM) This Earnings Season?
by Zacks Equity Research
Anthem (ANTM) is likely to gain from Q4 results on revenue and membership growth, partly offset by higher expenses.
Is a Beat in Store for HCA Healthcare (HCA) Q4 Earnings?
by Zacks Equity Research
HCA Healthcare (HCA) is likely to gain from higher admissions in Q4 earnings.
Hospital Industry Outlook: High Cost, Shift of Care Pose Concerns
by Zacks Equity Research
The hospital industry should grow on increased demand from an aging population, rising incidence of disease and technological innovation amid shortage of labor and shift of care to a low-cost setting.
Acadia Healthcare Down for Second Year, What Awaits in 2019?
by Zacks Equity Research
Shares of Acadia Healthcare (ACHC) seem to have no respite from its high debt and profitability concern in U.K. business.
Community Health Carries on Hospital Sale for Business Rejig
by Zacks Equity Research
Community Health (CYH) is set to sell hospital units for debt reduction and focusing on profitable business areas.
Acadia Healthcare (ACHC) Misses on Q3 Earnings, Trims View
by Zacks Equity Research
Acadia Healthcare's (ACHC) Q3 earnings missed estimates and declined year over year on increase in expenses.
Universal Health (UHS) Q3 Earnings Beat, 2018 View Narrows
by Zacks Equity Research
Universal Health's (UHS) Q3 benefits from an improved performance at both its segments.
Universal Health Services (UHS) Beats Q3 Earnings Estimates
by Zacks Equity Research
Universal Health Services (UHS) delivered earnings and revenue surprises of 11.50% and -1.06%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?
Universal Health Services (UHS) Q3 Earnings: A Beat in the Cards?
by Zacks Equity Research
United Health's (UHS) third quarter is likely to gain from solid segmental performances and higher number of admissions.
Universal Health Services (UHS) Q3 Earnings Preview: What to Watch Ahead of the Release
by Zacks Equity Research
Universal Health Services (UHS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
HCA Healthcare to Buy Mission Health for Portfolio Boost
by Zacks Equity Research
HCA Healthcare (HCA) to buy Mission Health for bracing its service portfolio and serve the people of western North Carolina in a better way.
Universal Health Services (UHS) Up 2.2% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Universal Health Services (UHS) reported earnings 30 days ago. What's next for the company? We take a look at earnings estimates for some clues.
Here's Why HCA Healthcare (HCA) Must be in Your Portfolio Now
by Zacks Equity Research
Increased earnings guidance, and strong inorganic and organic growth prospects poise HCA Healthcare (HCA) for growth.
Hospital Industry Outlook: Solid Fundamentals Promise Growth
by Zacks Equity Research
Aging population, investments in technology and a strong economy should drive the hospital industry's long-term growth
Acadia Healthcare (ACHC) Posts In-Line Q2 Earnings, Cuts View
by Zacks Equity Research
Acadia Healthcare (ACHC)'s second-quarter earnings grow on the back of extra beds procured by units facilities. However, the company trims its full-year view.
Community Health (CYH) Incurs Lower Loss Than Expected in Q2
by Zacks Equity Research
Community Health's (CYH) Q2 results suffer loss from decline in admissions.
Universal Health (UHS) Q2 Earnings Beat Estimates, Up Y/Y
by Zacks Equity Research
Universal Health's (UHS) second-quarter earnings benefit from solid performances by the Acute Care and Behavioral Hospitals.
HCA, UHS to Report Q2 Earnings on Jul 25: Key Predictions
by Zacks Equity Research
Medical stocks are expected to show lower profitability in Q2 earnings.